CrowdStrike to lay off 5% of staff, reaffirms forecasts

CrowdStrike to lay off 5% of staff, reaffirms forecasts

(Reuters) -CrowdStrike reiterated its fiscal 2026 first quarter and annual forecasts on Wednesday and announced a plan to cut about 500 roles, roughly 5% of its workforce, to reduce costs.The cybersecurity company will incur about $36 million to $53 million in charges...
Intel shareholders approve equity incentive plan, new CEO pay

Intel shareholders approve equity incentive plan, new CEO pay

SAN FRANCISCO (Reuters) -Intel shareholders on Tuesday approved a measure by the chipmaker aimed at topping up share reserves to attract and retain new employees, and compensation for its new CEO Lip-Bu Tan.Intel shares fell 1.6% in early afternoon trading after...
Cisco shows quantum networking chip, opens new lab 

Cisco shows quantum networking chip, opens new lab 

By Stephen NellisSAN FRANCISCO (Reuters) -Cisco Systems on Tuesday showed a prototype chip for networking quantum computers together and said it is opening a new lab in Santa Monica, California, to further pursue quantum computing.The chip uses some of the same...
Stressed US companies restructured more debt in April

Stressed US companies restructured more debt in April

By Shankar Ramakrishnan(Reuters) -Debt restructuring by financially stressed U.S. companies rose nearly 60% in April, data from JPMorgan showed on Tuesday, as businesses faced pressure from rising tariffs, inflation and capital markets volatility.These operations are...
US will not pay for California high-speed rail, Trump says

US will not pay for California high-speed rail, Trump says

By David Shepardson and Steve HollandWASHINGTON (Reuters) – The U.S. government will not pay for a high-speed rail line planned between Los Angeles and San Francisco, President Donald Trump told reporters at the White House on Tuesday, citing cost overruns.The...
Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharma imports to US surged in March as drugmakers look to avoid tariffs

By Michael ErmanNEW YORK (Reuters) -Pharmaceutical imports to the U.S. surged in March as drugmakers stocked up ahead of potential U.S. tariffs on their products, which have historically been exempt from such fees.Total imports of pharmaceutical products exceeded $50...

Tomorrow’s Secrets Delivered Today: Market Intelligence Report

Top Market Headlines U.S. Tariff Tensions Back in FocusMarkets turned cautious as the White House signaled possible pharmaceutical import tariffs from China. Major indices opened lower: S&P 500: ↓ 0.8% Dow Jones: ↓ 0.7% Nasdaq: ↓ 1.1% Pharma giants Pfizer (PFE)...